Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: prednisone attending: chief complaint: l knee pain major surgical or invasive procedure: l tka history of present illness: 59f with long history of l knee oa. past medical history: niddm,dyslipid,htn,asthema,osa-w/cpap,renal insuffic, social history: single, former smoker, has not smoked for 30 years. she drinks minimally. she is a travel consultant. family history: n/c physical exam: physical exam at the time of discharge: at the time of discharge: avss nad wound c/d/i without erythema /fhl/ta/gs intact silt distally pertinent results: 11:35pm plt count-307 11:35pm wbc-13.2* rbc-2.92* hgb-8.7* hct-24.8* mcv-85 mch-29.8 mchc-35.0 rdw-15.7* 11:35pm calcium-8.2* phosphate-5.5* magnesium-1.7 11:35pm estgfr-using this 11:35pm glucose-184* urea n-29* creat-1.6* sodium-135 potassium-4.3 chloride-100 total co2-25 anion gap-14 brief hospital course: the patient was admitted on and, later that day, was taken to the operating room by dr. for l tka without complication. please see operative report for details. postoperatively the patient did well. the patient was initially treated with a pca followed by po pain medications on pod#1. the patient received iv antibiotics for 24 hours postoperatively, as well as lovenox for dvt prophylaxis starting on the morning of pod#1. the patient was placed in a cpm machine with range of motion that started at 0-45 degrees of flexion before being increased to 90 degrees as tolerated. the drain was removed without incident on pod#1. she had respiratory distress and her oxygen saturations dropped into the 80s. she was transferred to the micu and was stabilized on cpap. the foley catheter was removed without incident on pod 2. the surgical dressing was removed on pod#2 and the surgical incision was found to be clean, dry, and intact without erythema or purulent drainage. she received 2 units prbc on pod 2 for a hct of 20. she was asymptomatic. while in the hospital, the patient was seen daily by physical therapy. labs were checked throughout the hospital course and repleted accordingly. at the time of discharge the patient was tolerating a regular diet and feeling well. the patient was afebrile with stable vital signs. the patient's hematocrit was stable, and the patient's pain was adequately controlled on a po regimen. the operative extremity was neurovascularly intact and the wound was benign. the patient was discharged to home with services or rehabilitation in a stable condition. the patient's weight-bearing status was wbat. the patient is to continue using the cpm machine advancing as tolerated to 0-100 degrees. micu course # hypoxia: pt was noted to hypoxic off of cpap in the pacu following lt total knee replacement. portable chest x-ray in the pacu notable for vessel cephalization. in the or and pacu she received a total fluid load of 1.3l, pt was give a total of 30mg furosemide for which she put out a vast amount of urine although interestingly enough her oxygenation failed to improve. differential negative pressure pulmonary edema as pt has not history of cardiac dysfunction and did not receive a vast amount of fluid in the or. treated with albuterol nebs. bnp 65. cardiac biomarkers flat. continued cpap. improved to 2l nc. # anemia: pot-op hct noted to be 6 points lower than her pre-op hct, pt's ebl noted to be minimal per surgery, pt also only received 1.3l in the or. no signs/symptoms of bleeding. #. leukocytosis: wbc noted to be elevated, however pt was post-op which likely explains wbc elevation. pt currently on cefazolin post-operatively. cultures negative thus far. #. diabetes: oral medications held as patient was not eating and patient in acute renal failure. covered with ssi. lisinopril held. #. s/p total knee replacement: pt is s/p lt tkr for osteoarthritis, currently on a dilaudid pca, placed in brace with hemovac drain in place. pt also on cefazolin post op. continued pca. d/c'ed ketorolac given acute renal failure. lovenox d/c'ed given acute renal failure and patient started on heparin sq tid for dvt ppx. #. acute renal failure on chronic renal insufficeny: pt's creatinine elevated to 1.6, over past few months pt's creatinine has been elevated 1.3. diabetes medications and lisinopril as above. #. htn: pt has a history of htn, currently sbp have ranged in the low 100s. will hold lisinopril and hctz as pt's creatinine is elevated at 1.6. held lisinopril and hctz as creatinine is elevated at 1.6. #. osa: pt has diagnosis of osa, she usually uses cpap during naps, at bedtime at 8cm. currently on cpap settings now. likely would benefit from reassessment of respiratory support as last sleep study was 6 years ago - should follow up as an out patient upon discharge. #. depression: continued home regimen of venlafaxine #. ppx: heparin gtt given renal failure, pantoprazole. #. fen: currently on sips, adat to diabetic/cardiac diet. #. full code medications on admission: e f f e x o r , g l i p i z ide,ibuprof,lisinopril,metformin,prilosec,valium,vicodin,mvi,ca, discharge medications: 1. hydromorphone 2 mg tablet sig: one (1) tablet po q4-6h () as needed. disp:*65 tablet(s)* refills:*0* 2. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours). 3. enoxaparin 40 mg/0.4 ml syringe sig: one (1) subcutaneous once a day for 3 weeks. disp:*21 * refills:*0* 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 5. senna 8.6 mg tablet sig: 1-2 tablets po bid (2 times a day) as needed. 6. multivitamin tablet sig: one (1) cap po daily (daily). 7. venlafaxine 150 mg capsule, sust. release 24 hr sig: one (1) capsule, sust. release 24 hr po daily (daily). 8. glipizide 10 mg tablet sig: one (1) tablet po daily (daily). 9. metformin 500 mg tablet sig: one (1) tablet po qam (once a day (in the morning)). 10. metformin 1,000 mg tablet sig: one (1) tablet po qpm (once a day (in the evening)). 11. diazepam 5 mg tablet sig: one (1) tablet po prn (as needed). 12. prilosec 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. 13. venlafaxine 75 mg capsule, sust. release 24 hr sig: two (2) capsule, sust. release 24 hr po daily (daily). 14. diazepam 5 mg tablet sig: one (1) tablet po daily (daily) as needed for anxiety. 15. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). 16. hydrochlorothiazide 12.5 mg capsule sig: one (1) capsule po daily (daily). 17. glipizide 10 mg tablet sig: one (1) tablet po daily (daily). 18. metformin 500 mg tablet sig: one (1) tablet po qam (once a day (in the morning)). 19. metformin 500 mg tablet sig: two (2) tablet po qpm (once a day (in the evening)). discharge disposition: extended care facility: - discharge diagnosis: l knee oa discharge condition: stable discharge instructions: discharge instructions experience severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers >101.5, shaking chills, redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. please follow up with your pcp regarding this admission and any new medications and refills. 3. resume your home medications unless otherwise instructed. 4. you have been given medications for pain control. please do not operate heavy machinery or drink alcohol when taking these medications. as your pain improves, please decrease the amount of pain medication. this medication can cause constipation, so you should drink plenty of water daily and take a stool softener (e.g., colace) as needed to prevent this side effect. 5. you may not drive a car until cleared to do so by your surgeon or your primary physician. 6. please keep your wounds clean. you may get the wound wet or take a shower starting 5 days after surgery, but no baths or swimming for at least 4 weeks. no dressing is needed if wound continues to be non-draining. any stitches or staples that need to be removed will be taken out by a visiting nurse at 2 weeks after your surgery. 7. please call your surgeon's office to schedule or confirm your follow-up appointment at 4 weeks. 8. please do not take any nsaids (i.e. celebrex, ibuprofen, advil, motrin, etc). 9. anticoagulation: please continue your lovenox for 3 weeks to prevent deep vein thrombosis (blood clots). after completing the lovenox, please take aspirin 325mg twice daily for an additional three weeks. 10. wound care: please keep your incision clean and dry. it is okay to shower after pod#5 but do not take a tub-bath or submerge your incision until 4 weeks after surgery. please place a dry sterile dressing on the wound each day if there is drainage, otherwise leave it open to air. check wound regularly for signs of infection such as redness or thick yellow drainage. staples will be removed by vna in 2 weeks. if you are going to rehab, the rehab facility can remove the staples at 2 weeks. 11. vna (once at home): home pt/ot, dressing changes as instructed, wound checks, and staple removal at 2 weeks after surgery. 12. activity: weight bearing as tolerated on the operative leg. no strenuous exercise or heavy lifting until follow up appointment. ***continue to use your cpm machine as directed.*** physical therapy: physical therapy -- wbat. cpm advancing as tolerated to 0-100. lovenox injections. wound checks. vna to remove staples at 2 weeks. treatments frequency: physical therapy -- wbat. ***cpm advancing as tolerated to 0-100.*** lovenox injections. wound checks. vna to remove staples at 2 weeks. followup instructions: provider: , : date/time: 11:40 procedure: transfusion of packed cells total knee replacement diagnoses: obstructive sleep apnea (adult)(pediatric) anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified asthma, unspecified type, unspecified depressive disorder, not elsewhere classified chronic kidney disease, unspecified other and unspecified hyperlipidemia acute edema of lung, unspecified osteoarthrosis, localized, not specified whether primary or secondary, lower leg 

Answer: The patient is high likely exposed to